CGT

CGTBiologicstaleJuno Therapeutics, a Subsidiary…Phase 2

JCARH125 (JCARH125)

Non Hodgkin Lymphoma; Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+3

효능 ORR 42.9%임상시험 2상태 ACTIVE

CGTBiologicstaleOriCell Therapeutics Co., Ltd.Phase 2

OriCAR-017 (OriCAR-017)

Relapsed and/or Refractory Multiple Myeloma · Neoplasms, Plasma Cell

#NeoplasmsPlasmaCell#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 2상태 RECRUITING

CGTBiologicstaleAutolus LimitedPhase 2

AUTO CAR T cell therapy (AUTO CAR T cell therapy)

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy; Multiple Myeloma · Patients Followed for up to 15 Years Fol

JCARH125 (JCARH125)

OriCAR-017 (OriCAR-017)

AUTO CAR T cell therapy (AUTO CAR T cell therapy)

Anti-GPRC5D CAR-T cells infusion (Anti-GPRC5D CAR-T cells infusion)

Autologous BCMA CAR-T cells and CD19 CAR-T cells (Autologous BCMA CAR-T cells and CD19 CAR-T cells)

Autologous BCMA-targeting CAR T cells (Autologous BCMA-targeting CAR T cells)

Autologous CAR-T cell therapy expressing the BAFF-ligand. (Autologous CAR-T cell therapy expressing the BAFF-ligand.)

BCMA Targeted CAR T-cells (BCMA Targeted CAR T-cells)

BCMA targeted prime CAR-T cells (BCMA targeted prime CAR-T cells)

BCMA-CART cells (BCMA-CART cells)

BCMA-CS1 cCAR T cells (BCMA-CS1 cCAR T cells)

BCMA-PD1-CART Cell (BCMA-PD1-CART Cell)

0.50 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (0.50 x 10^6 cells/kg))

0.75 x10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg))

1 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (1 x 10^6 cells/kg))

2.5 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (2.5 x 10^6 cells/kg))

BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell (BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell)

BCMA-UCART (BCMA-UCART)

BCMA/CD19 Dual-Target CAR-T (BCMA/CD19 Dual-Target CAR-T)

BCMA/CD19 dual-target CAR-T cell immunotherapy (BCMA/CD19 dual-target CAR-T cell immunotherapy)

CGT

JCARH125 (JCARH125)

OriCAR-017 (OriCAR-017)

AUTO CAR T cell therapy (AUTO CAR T cell therapy)

Anti-GPRC5D CAR-T cells infusion (Anti-GPRC5D CAR-T cells infusion)

Autologous BCMA CAR-T cells and CD19 CAR-T cells (Autologous BCMA CAR-T cells and CD19 CAR-T cells)

Autologous BCMA-targeting CAR T cells (Autologous BCMA-targeting CAR T cells)

Autologous CAR-T cell therapy expressing the BAFF-ligand. (Autologous CAR-T cell therapy expressing the BAFF-ligand.)

BCMA Targeted CAR T-cells (BCMA Targeted CAR T-cells)

BCMA targeted prime CAR-T cells (BCMA targeted prime CAR-T cells)

BCMA-CART cells (BCMA-CART cells)

BCMA-CS1 cCAR T cells (BCMA-CS1 cCAR T cells)

BCMA-PD1-CART Cell (BCMA-PD1-CART Cell)

0.50 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (0.50 x 10^6 cells/kg))

0.75 x10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg))

1 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (1 x 10^6 cells/kg))

2.5 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (2.5 x 10^6 cells/kg))

BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell (BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell)

BCMA-UCART (BCMA-UCART)

BCMA/CD19 Dual-Target CAR-T (BCMA/CD19 Dual-Target CAR-T)

BCMA/CD19 dual-target CAR-T cell immunotherapy (BCMA/CD19 dual-target CAR-T cell immunotherapy)

CGT

JCARH125 (JCARH125)

OriCAR-017 (OriCAR-017)

AUTO CAR T cell therapy (AUTO CAR T cell therapy)

Anti-GPRC5D CAR-T cells infusion (Anti-GPRC5D CAR-T cells infusion)

Autologous BCMA CAR-T cells and CD19 CAR-T cells (Autologous BCMA CAR-T cells and CD19 CAR-T cells)

Autologous BCMA-targeting CAR T cells (Autologous BCMA-targeting CAR T cells)

Autologous CAR-T cell therapy expressing the BAFF-ligand. (Autologous CAR-T cell therapy expressing the BAFF-ligand.)

BCMA Targeted CAR T-cells (BCMA Targeted CAR T-cells)

BCMA targeted prime CAR-T cells (BCMA targeted prime CAR-T cells)

BCMA-CART cells (BCMA-CART cells)

BCMA-CS1 cCAR T cells (BCMA-CS1 cCAR T cells)

BCMA-PD1-CART Cell (BCMA-PD1-CART Cell)

0.50 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (0.50 x 10^6 cells/kg))

0.75 x10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg))

1 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (1 x 10^6 cells/kg))

2.5 x 10^6 cells/kg (BCMA-TGFβ CAR-T cells, BCMA-TGFβ CAR-T cells (2.5 x 10^6 cells/kg))

BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell (BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell)

BCMA-UCART (BCMA-UCART)

BCMA/CD19 Dual-Target CAR-T (BCMA/CD19 Dual-Target CAR-T)

BCMA/CD19 dual-target CAR-T cell immunotherapy (BCMA/CD19 dual-target CAR-T cell immunotherapy)